Needle anxiety is one of the most common barriers to vaccination compliance across the lifespan, yet clinical attention has focused almost entirely on pharmacological solutions like topical anesthetics. A rigorous meta-analysis now quantifies exactly which psychological tools work — and by how much — offering practitioners an evidence hierarchy they can act on without prescriptions or added costs.
Drawing on 57 randomized and quasi-randomized trials, this Cochrane-guided systematic review separated interventions by age group to produce intervention-specific effect estimates. For infants under 12 months, toy-based distraction yielded the largest standardized mean difference (SMD = −3.68), though with low certainty evidence. Singing also showed meaningful benefit (SMD = −0.60, low certainty). In children and adolescents older than 12 months, music distraction emerged as the preferred intervention with moderate certainty (SMD = −0.38), followed by digital games (SMD = −0.74, low certainty) and virtual reality (SMD = −0.51, low certainty). The threshold for clinical relevance was set at SMD > 0.2, placing most preferred interventions well above trivial effect size — particularly in infants.
This review is important for several reasons that go beyond its statistical findings. First, it confirms that psychological distraction is not a soft placebo effect but a quantifiably potent intervention, particularly in preverbal infants where behavioral distress is the primary measurable outcome. Second, the stratification by age group reflects developmentally appropriate thinking rarely seen in pain-management literature. Third, the moderate-certainty rating for music in older children stands out — most interventions only reached low or very low certainty, underscoring how underpowered this research area remains. Key limitations include the near-exclusive focus on pediatric populations; the adult lifespan is largely unstudied. The absence of head-to-head comparisons between top-ranked interventions also leaves optimal sequencing unanswered. For public health programs seeking low-cost, scalable tools to improve vaccination uptake, however, these findings are immediately actionable.